The smoking cessation drug, Champix, has been recalled over concerns the product may contain elevated levels of nitrosamines.
The Medicines and Healthcare products Regulatory Agency (MHRA) requested the manufacturer, Pfizer, to recall all batches of its product as a ‘precautionary measure’ due to the presence of levels of N-nitroso-varenicline above the acceptable level set by the MHRA.
NDMA has been identified as a risk factor in the development of certain cancers and has genotoxic potential, the MHRA said.
Pharmacists should stop dispensing the affected products (Champix 0.5mg and 1mg tablets) immediately, quarantine all remaining stock and return it to the supplier, the MHRA explained.
In a supply disruption alert, the Department of Health and Social Care (DHSC) said patients who are currently taking this medication will require a review and switching to nicotine replacement therapy (NRT).
Prescribers starting patients on smoking cessation treatments should consider prescribing NRT or bupropion 150mg prolonged-release tablets.
It also said that no new patients should be initiated on Champix.
There have been ongoing supply issues of Champix since June, following several global regulatory investigations relating to the presence of nitrosamine impurities above Pfizer’s acceptable level of daily intake in numerous batches.
Pfizer said: ‘For those patients currently prescribed Champix, we believe the benefits outweigh the very low potential risks, if any, posed by nitrosamine exposure from varenicline on top of other common sources over a lifetime.’
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.